SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-19-005007
Filing Date
2019-05-14
Accepted
2019-05-14 17:01:23
Documents
53
Period of Report
2019-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q aptx-20190331x10q.htm 10-Q 1145881
2 EX-31.1 aptx-20190331ex31116e13a.htm EX-31.1 24008
3 EX-31.2 aptx-20190331ex31248ea60.htm EX-31.2 24024
4 EX-32.1 aptx-20190331ex32168857a.htm EX-32.1 16510
  Complete submission text file 0001558370-19-005007.txt   4189089

Data Files

Seq Description Document Type Size
5 EX-101.INS aptx-20190331.xml EX-101.INS 886970
6 EX-101.SCH aptx-20190331.xsd EX-101.SCH 28676
7 EX-101.CAL aptx-20190331_cal.xml EX-101.CAL 31378
8 EX-101.DEF aptx-20190331_def.xml EX-101.DEF 101361
9 EX-101.LAB aptx-20190331_lab.xml EX-101.LAB 242342
10 EX-101.PRE aptx-20190331_pre.xml EX-101.PRE 199218
Mailing Address 909 DAVIS STREET SUITE 600 EVANSTON IL 60201
Business Address 1801 MAPLE AVENUE SUITE 4300 EVANSTON IL 60201 847-871-0377
Aptinyx Inc. (Filer) CIK: 0001674365 (see all company filings)

IRS No.: 474626057 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38535 | Film No.: 19823643
SIC: 2834 Pharmaceutical Preparations